Get the Stockscreener App
0.5757
1.71%
0.0097
After Hours:
.57
-0.0057
-0.99%
Pavmed Inc stock is traded at $0.5757, with a volume of 61,745.
It is up +1.71% in the last 24 hours and down -4.10% over the past month.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
See More
Previous Close:
$0.566
Open:
$0.56
24h Volume:
61,745
Relative Volume:
0.41
Market Cap:
$9.84M
Revenue:
$4.03M
Net Income/Loss:
$24.32M
P/E Ratio:
-0.1339
EPS:
-4.3008
Net Cash Flow:
$-45.76M
1W Performance:
-1.69%
1M Performance:
-4.10%
6M Performance:
-13.30%
1Y Performance:
-33.44%
1-Day Range:
$0.55
$0.5876
1-Week Range:
$0.55
$0.5999
52-Week Range:
$0.542
$1.90
Pavmed Inc Stock (PAVM) Company Profile
Name
Pavmed Inc
Sector
Industry
Phone
(212) 949-4319
Address
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.5757 | 9.79M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-05-20 | Initiated | Ascendiant Capital Markets | Buy |
| Jun-28-18 | Initiated | Maxim Group | Buy |
Pavmed Inc Stock (PAVM) Latest News
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
How strong is PAVmed Inc. company’s balance sheetChart Pattern Planner For Beginners - jammulinksnews.com
PAVmed CEO and CFO to Present Q2 2025 Results and Growth Strategy Update on August 14 - Stock Titan
Should I hold or sell PAVmed Inc. stock in 2025Earnings Report Insights With High Returns - jammulinksnews.com
Why PAVmed Inc. stock attracts strong analyst attentionGrowth Based Investment Plan Guidance Highlighted - beatles.ru
When is PAVmed Inc. stock expected to show significant growthDaily Trading Recommendation To Watch Now - jammulinksnews.com
Real Time Chart Alerts Flash Bullish on PAVmed Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
PAVmed granted 180-day extension to meet Nasdaq minimum bid price - Investing.com Australia
PAVmed Granted Nasdaq Extension for Compliance - TipRanks
Cancer Prevention Leader Lucid Diagnostics to Reveal Q2 2025 Financial Results and Growth Strategy - Stock Titan
PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule - 富途牛牛
Published on: 2025-07-29 22:46:56 - metal.it
RSI Reset May Fuel Rebound in PAVmed Inc.AI Powered High Return Stock Calls Dominate Watchlists - metal.it
How did PAVM's revenue and expenses trend in Q4 2024? - AInvest
Does PAVmed Inc. stock perform well during market downturnsTriple-digit returns - jammulinksnews.com
What institutional investors are buying PAVmed Inc. stockRapidly growing investment returns - jammulinksnews.com
What is the dividend policy of PAVmed Inc. stockSmart Portfolio Signals To Watch Now - jammulinksnews.com
How PAVmed Inc. stock performs during market volatilityMoney Making Low Risk Plans - beatles.ru
Is PAVmed Inc. a growth stock or a value stockCapitalize on momentum stocks early - jammulinksnews.com
Is it the right time to buy PAVmed Inc. stockBuild a portfolio that grows with the market - jammulinksnews.com
How does PAVmed Inc. compare to its industry peersDynamic growth stocks - jammulinksnews.com
PAVmed Inc. Stock Analysis and ForecastExplosive capital appreciation - PrintWeekIndia
What analysts say about PAVmed Inc. stockFree Consultation - Autocar Professional
Will PAVmed Inc. stock split in the near futureFree Market Dynamics Reports - jammulinksnews.com
What drives PAVmed Inc. stock pricePhenomenal capital appreciation - PrintWeekIndia
Is PAVmed Inc. a good long term investmentFree Consultation - PrintWeekIndia
Pavmed Inc Stock (PAVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):